Gene · 1749
NIH grants1,185
NIH grants whose papers are about the gene, through NIH's grant-paper links.
121 to 140 of 1,185
Download this page as JSON| Grant | Title | DLX5 papers | Newest fiscal year |
|---|---|---|---|
| R01NS123912 | MAPPING RETINOTECTAL CIRCUITS FOR VISUAL-EVOKED INNATE BEHAVIORS | 1 | 2025 |
| R25MH060482 | TRAINING THE NEXT GENERATION OF MENTAL HEALTH RESEARCHERS | 1 | 2025 |
| R35GM119831 | Functional elucidation of the sequence-encoded regulatory activity of enhancers in vivo in the brain | 1 | 2025 |
| R35GM124755 | Sub-Cellular Mass Spectrometry Discoveries: Metabolic Encoding of the Embryonic Body Plan | 1 | 2025 |
| R35GM127069 | Gene Expression in Amphibian Development | 1 | 2025 |
| R35GM128645 | Mechanisms and impacts of chromatin looping | 1 | 2025 |
| R35NS111619 | Glutamate receptors and human neurological disease | 1 | 2025 |
| R37CA237022 | Master regulator transcription factors promote esophageal neoplastic evolution | 1 | 2025 |
| R37DA023999 | Origin of Cortical Species-specific Distinctions | 1 | 2025 |
| R90DE022528 | Doctoral and Post-doctoral Training in Craniofacial Biology | 1 | 2025 |
| RM1HG009490 | Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease | 1 | 2025 |
| RM1HG011014 | Center for Integrated Cellular Analysis | 1 | 2025 |
| RM1HG011543 | Center for Live Cell Genomics | 1 | 2025 |
| RM1MH132648 | High-throughput in vivo and in vitro functional and multi-omics screens of neuropsychiatric and neurodevelopmental disorder risk genes | 1 | 2025 |
| T32AG049688 | Research Training in the Neuroscience of Aging | 1 | 2025 |
| T32AR056950 | Musculoskeletal Research Training Program | 1 | 2025 |
| T32CA009599 | Training of Academic Surgical Oncologists | 1 | 2025 |
| T32DE007306 | Oral and Craniofacial Sciences Health Research Training | 1 | 2025 |
| T32DK007028 | Training Program in Endocrinology | 1 | 2025 |
| T32ES007046 | Molecular Pathways to Pathogenesis in Toxicology | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1749/grants?page=7